Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000819050-22-000145
Filing Date
2022-09-02
Accepted
2022-09-02 16:07:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 a20220902s1.htm S-1 342117
2 EX-FILING FEES a20220902s1ex107.htm EX-FILING FEES 26469
3 EX-5.1 a20220902s1ex51.htm EX-5.1 18001
4 EX-23.1 a20220902s1ex231.htm EX-23.1 2360
5 bbilogohr.jpg GRAPHIC 71984
6 fdlogo1.jpg GRAPHIC 12234
  Complete submission text file 0000819050-22-000145.txt   506139
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-267254 | Film No.: 221225166
SIC: 2836 Biological Products, (No Diagnostic Substances)